Thrive Capital Management (Pennsylvania)’s Sanofi SNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-5,176
| Closed | -$257K | – | 191 |
|
|
2023
Q4 | $257K | Sell |
5,176
-2,192
| -30% | -$109K | 0.14% | 115 |
|
|
2023
Q3 | $395K | Sell |
7,368
-16
| -0.2% | -$858 | 0.22% | 76 |
|
|
2023
Q2 | $398K | Buy |
7,384
+1,942
| +36% | +$105K | 0.23% | 75 |
|
|
2023
Q1 | $294K | Buy |
+5,442
| New | +$294K | 0.19% | 93 |
|
|
2022
Q1 | – | Sell |
-9,464
| Closed | -$474K | – | 116 |
|
|
2021
Q4 | $474K | Sell |
9,464
-8,464
| -47% | -$424K | 0.31% | 67 |
|
|
2021
Q3 | $864K | Buy |
17,928
+2,157
| +14% | +$104K | 0.64% | 47 |
|
|
2021
Q2 | $831K | Buy |
15,771
+5,449
| +53% | +$287K | 0.65% | 48 |
|
|
2021
Q1 | $511K | Buy |
10,322
+2,874
| +39% | +$142K | 0.48% | 56 |
|
|
2020
Q4 | $362K | Buy |
+7,448
| New | +$362K | 0.39% | 59 |
|